Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
By A Mystery Man Writer
Description
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2016/08/the_specialistsmri1.jpg)
Health Archives — Page 34 of 107 — Harvard Gazette
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://images.newscientist.com/wp-content/uploads/2001/12/dn1690-1_370.jpg)
Sickle cell treatment marks gene therapy milestone
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://i.guim.co.uk/img/media/00b79fbf7f15b2bc7ce496c4043c905855faa02a/0_341_5121_3073/master/5121.jpg?width=1200&height=900&quality=85&auto=format&fit=crop&s=371056477d2d4d51e86b146ec09f33eb)
The daily dilemmas of a student with sickle cell anaemia, Students
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://www.uchicagomedicine.org/-/media/images/ucmc/module-images/slider/pediatric-hematology/ucm_sc_infographic_web-08.png)
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://www.uchicagomedicine.org/-/media/images/ucmc/module-images/slider/pediatric-hematology/ucm_sc_infographic_web-07.png)
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://www.scienceboard.net/user/images/content_images/sup_humd/2019_10_02_17_22_4368_291_Image.jpg)
Forward-oriented gene therapy improves treatment for sickle cell disease
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2021/06/iStock-1059145434-150x150.jpg)
Gene editing shows promise as sickle cell therapy — Harvard Gazette
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
PDF) Editing Human DNA Moral and social implications of germline genetic modification
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://cdn.kscope.io/a3d9ebf5362fc674029921d969c83da6-g2017031018565610431421.jpg)
SEC Filing CRISPR Therapeutics
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://image.isu.pub/220702015044-4d9365d64a5a4c2158eb9d8b2e106d54/jpg/page_1.jpg)
Dartmouth Undergraduate Journal of Science - Winter/Spring 2022 by dartmouthjournalofscience - Issuu
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2020/02/112117_Liu_David_273_2500.jpg)
Gene editing shows promise as sickle cell therapy — Harvard Gazette
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://img-cdn.thepublive.com/fit-in/1200x675/medriva/media/post_banners/content/uploads/2023/12/new-gene-therapies-for-sickle-cell-disease-20231215223530.jpg)
Gene Therapies for Sickle Cell Disease: A Promise Yet to Reach the Neediest
World-first gene therapy for 2 blood disorders — sickle cell and thalassemia — approved
from
per adult (price varies by group size)